Form 4: Abbott Laboratories Executive Vice President Louis H. Morrone Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President Louis H. Morrone of Abbott Laboratories reports the disposition of shares and updates to beneficial ownership.
Summary
- Louis H. Morrone, an Executive Vice President at Abbott Laboratories, filed a Form 4 detailing changes in beneficial ownership of Abbott Laboratories stock.
- On February 29, 2024, 3,455 common shares were disposed of at a price of $120.05.
- On March 1, 2024, 801 common shares were disposed of at a price of $118.5.
- Following these transactions, Morrone directly owns 62,968 common shares.
- Morrone also indirectly owns 2,562 shares through a Profit Sharing Trust.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing, reflecting standard stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive stock transactions.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Disposition of 3,455 common shares at $120.05 per share. |
| 03/01/2024 | Disposition of 801 common shares at $118.5 per share; balance in the Abbott Laboratories Stock Retirement Trust as of this date. |
| 03/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.